Schering-Plough Zetia Could Be More Important Growth Product Than Claritin

Schering-Plough's cholesterol agent Zetia could be an even larger growth driver than Claritin, CEO Richard Kogan told analysts at the company's annual meeting on July 16

More from Archive

More from Pink Sheet